Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2004
09/07/2004US6787536 Hydroxamic acid derivatives
09/07/2004US6787535 Indole derivatives with 5HT6 receptor affinity
09/07/2004US6787534 Sulfonamide-containing heterocyclic compounds
09/07/2004US6787532 Formulation containing anti-inflammatory androstane derivatives
09/07/2004US6787531 Pharmaceutical composition for use as a contraceptive
09/07/2004US6787530 Use of pregnane-diones as analgesic agents
09/07/2004US6787529 Synergistic mixture of vitamin d and corticosteroids; skin disorders
09/07/2004US6787527 Administering to said subject an amount of hydroxocobalamin, methylcobalamin or adenocobalamin sufficient to effect said treatment.
09/07/2004US6787526 Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides
09/07/2004US6787525 Method of treating hiv infections and/or cancer diseases
09/07/2004US6787522 Antibacterial agents
09/07/2004US6787517 Agent and methods for treating pain
09/07/2004US6787365 Inhibition of L-selectin and P-selectin mediated binding using heparin
09/07/2004US6787346 Kinase capable of site-specific phosphorylation of IκBα
09/07/2004US6787342 Paste formulations
09/07/2004US6787321 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products
09/07/2004US6787319 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's disease
09/07/2004US6787164 Composition and method for treating the effects of diseases and maladies
09/07/2004US6787161 Anti-cancer compounds
09/07/2004US6787160 Compositions and methods for high sorption of skin materials and delivery of sulfur
09/07/2004US6787157 Multiphase active ingredient-containing formulations
09/07/2004US6787155 Delay release formulation of a non-steroidal anti-inflammatory drug (nsaid) and a mixture containing a prostaqlandin and one or more excipients; for therapy of osteoarthritis or rheumatoid arthritis
09/07/2004US6787151 Mixture of flavonoids, vegetable protein and sterols
09/07/2004US6787149 Topical application of opioid analgesic drugs such as morphine
09/07/2004US6787148 Chemical peeling agent
09/07/2004US6787131 Method for enhancing integrity of epithelium using retinoic acid
09/07/2004US6787039 Special amino acid mixture suitable for dialysis solution for hemodialysis
09/07/2004CA2311510C Skin care composition
09/07/2004CA2174645C Polycyclic antiparasitic agents, process and strain for their preparation and their use
09/07/2004CA2173594C Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
09/07/2004CA2166898C Novel structural analogues of vitamin d
09/07/2004CA2105709C Substituted cyclohexane derivatives, processes for their preparation and the use of the compounds for treating diseases
09/07/2004CA2102777C Novel compositions based on taxane class derivatives
09/07/2004CA2093770C Aspartic acid derivatives, their preparation and use
09/05/2004CA2428711A1 Formulations and methods of delivery of intact tocopheryl succinate to humans
09/03/2004CA2456410A1 Stabilised pharmaceutical composition comprising an extented release non-steroidal anti-inflammatory agent and an immediate release prostaglandin
09/02/2004WO2004074831A1 Treatment of hypertension
09/02/2004WO2004074812A2 Library of biphenyl derivatives useful for identifying compounds having both beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
09/02/2004WO2004074450A2 Combination therapy for treating protein deficiencies
09/02/2004WO2004074445A2 Model for studying the role of genes in tumor resistance to chemotherapy
09/02/2004WO2004074444A2 Ferric organic compounds, uses thereof and methods of making same
09/02/2004WO2004074350A2 Bicalutamide polymorphs
09/02/2004WO2004074319A1 Physiologically active peptides and drugs containing the same
09/02/2004WO2004074309A1 Antitumoral d-homoestra-1, 3, 5 (10)-trien-3-yl 2-substituted sulfamates
09/02/2004WO2004074308A1 Antitumoral 18a-homoestra-1,3,5(10)-trien-3-yl 2-substituted sulfamates
09/02/2004WO2004074307A1 2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action
09/02/2004WO2004074306A1 A continuous process for the production of r-rofleponide
09/02/2004WO2004074299A1 Platinum(ii) complexes of n-substituted amino dicarboxylates and the preparation method thereof
09/02/2004WO2004074297A1 Aminophosphonic acid derivatives, addition salts thereof and s1p receptor modulators
09/02/2004WO2004074295A1 Thiazole cycle polymers, process for producing the same, synthesis intermediates thereof and utilization of the same
09/02/2004WO2004074289A1 6-substituted imidazopyrazines
09/02/2004WO2004074284A1 Oxazole-derivatives as ppar agonists
09/02/2004WO2004074283A1 N-heterocyclyl-substituted amino-thiazole derivatives as protein kinase inhibitors
09/02/2004WO2004074282A1 Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them
09/02/2004WO2004074278A1 Novel compounds
09/02/2004WO2004074277A1 N-aryl- or n-heteroarylpiperazine derivative and medicine containing the same
09/02/2004WO2004074276A1 BIPHENYL DERIVATIVES HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
09/02/2004WO2004074272A1 Anthelmintic agents and insecticidal compositions
09/02/2004WO2004074271A1 Nitrate esters of phenylaminothiophenacetic acid derivatives
09/02/2004WO2004074270A2 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
09/02/2004WO2004074266A1 Hiv inhibiting 1,2,4-triazines
09/02/2004WO2004074262A1 Hiv replication inhibiting pyrimidines and triazines
09/02/2004WO2004074261A1 Hiv replication inhibiting pyrimidines and triazines
09/02/2004WO2004074258A1 Novel sulphated imidazole derivatives, method for production thereof, novel intermediates obtained, application thereof as medicaments and pharmaceutical compositions comprising the above
09/02/2004WO2004074257A1 Non-nucleoside reverse transcriptase inhibitors
09/02/2004WO2004074249A2 Synthesis of peloruside a and analogs thereof for use as antitumor agents
09/02/2004WO2004074248A2 Isolation and structure of cribrostatin 6
09/02/2004WO2004074247A2 A1 adenosine receptor antagonists
09/02/2004WO2004074246A2 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
09/02/2004WO2004074236A1 Novel transcriptional factor, process for producing the same and use thereof
09/02/2004WO2004074235A1 Transdermal penetration enhancers
09/02/2004WO2004074224A1 Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them
09/02/2004WO2004074218A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
09/02/2004WO2004074215A1 Process for preparation of clopidogrel, its salts and pharmaceutical compositions
09/02/2004WO2004074132A1 Methods of stabilizing azithromycin during storage by packaging in a gas impermeable container
09/02/2004WO2004073767A2 Regulation of blood pressure by coded nerve signals
09/02/2004WO2004073748A1 Aqueous suspension medicine
09/02/2004WO2004073721A1 A food-supplement composition suitable for promoting iron absorption
09/02/2004WO2004073720A1 Use of pvp-iodine liposomes for treatment of acne
09/02/2004WO2004073719A1 A combined therapy comprising an indolopyrrolocarbazole derivative and another antitumor agent
09/02/2004WO2004073718A1 Therapeutic agent for hemorrhoidal disease
09/02/2004WO2004073717A1 Blood-vessel-growth promoter
09/02/2004WO2004073716A1 Method for treating severe heart failure and medicament therefor
09/02/2004WO2004073715A1 Antifungal agents
09/02/2004WO2004073714A1 Use of palonosetron treating post-operative nausea and vomiting
09/02/2004WO2004073713A1 Pirfenidone gel preparation
09/02/2004WO2004073712A1 Pharmaceutical combinations comprising a nos inhibitor and an nmda receptor antagonist
09/02/2004WO2004073711A2 Methods involving pde4, compositions, and the screening thereof, for the treatment of degenerative ocular pathologies
09/02/2004WO2004073710A1 Treatment of diseases caused by ljungan virus by using pleconaril
09/02/2004WO2004073709A1 Antimicrobial agents
09/02/2004WO2004073708A1 Brinzolamide and brimonidine for treating ocular conditions
09/02/2004WO2004073707A1 Topical composition containing alkyl gallate or alkyl hydroxybenzoate or phenol alkyloxy as agent against acne
09/02/2004WO2004073706A1 Drug for reducing side effects in ribavirin interferon combination therapy
09/02/2004WO2004073704A1 New combination
09/02/2004WO2004073703A1 Glycinamide derivative for inhibiting hiv replication
09/02/2004WO2004073702A1 Buccal cavity treatment composition and corresponding uses thereof
09/02/2004WO2004073700A1 Composition comprising cysteamine for improving immunity of animals
09/02/2004WO2004073699A1 Pharmaceuticals comprising shikonins as active constituent
09/02/2004WO2004073698A1 Therapeutic use of acyl glycerols and the nitrogen- and sulphur-containing analogues therof
09/02/2004WO2004073694A1 Method to treat chronic heart failure and/or elevated cholesterol levels